Merck Enters into Licensing Deal with Five Indian Companies for Supply of Oral Covid-19 Drug
Recently, Merck, also known as MSD, has entered into licensing agreements with five Indian generics drug manufacturers to manufacture and supply oral Covid-19 drug Molnupiravir. MSD India is a wholly-owned subsidiary of Merck Sharp & Dohme (MSD) and is known as Merck & Co., Inc, in the United States and Canada. Under the agreements, Merck will provide […]